---
figid: PMC7894237__11_2021_1445_Fig4_HTML
figtitle: Targets of anti-rheumatoid agents in the host inflammatory pathway in COVID-19
  infection
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC7894237
filename: 11_2021_1445_Fig4_HTML.jpg
figlink: pmc/articles/PMC7894237/figure/Fig4/
number: F4
caption: The targets of anti-rheumatoid agents in the host inflammatory pathway in
  COVID-19 infection. The IL-1, IL-6, and IFNs bind to their own receptors (IL-1RI,
  sIL-6R, IFNAR, respectively) and trigger specific signaling cascades to activate
  the generation of multiple cytokines. IL-1 inhibitors, IL-6 inhibitors, and JAK
  inhibitors (ruxolitinib, tofacitinib, baricitinib, peficitinib, fedratinib, and
  upadacitinib) can limit cytokine storm and hyper-inflammation by suppressing these
  signaling cascades. IL interleukin, IFN interferones, IFNAR type I IFNs receptor,
  ISGF IFN-stimulated gene factor, R receptor, sIL-6R soluble interleukin receptor,
  JAK Janus kinase, STAT signal transducer and activator of transcription, NF-κB nuclear
  factor κB. Figure created using BioRender software
papertitle: Pharmacological mechanism of immunomodulatory agents for the treatment
  of severe cases of COVID-19 infection.
reftext: Zahra Bahari, et al. Inflamm Res. 2021 Feb 19 :1-17.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9497929
figid_alias: PMC7894237__F4
figtype: Figure
redirect_from: /figures/PMC7894237__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7894237__11_2021_1445_Fig4_HTML.html
  '@type': Dataset
  description: The targets of anti-rheumatoid agents in the host inflammatory pathway
    in COVID-19 infection. The IL-1, IL-6, and IFNs bind to their own receptors (IL-1RI,
    sIL-6R, IFNAR, respectively) and trigger specific signaling cascades to activate
    the generation of multiple cytokines. IL-1 inhibitors, IL-6 inhibitors, and JAK
    inhibitors (ruxolitinib, tofacitinib, baricitinib, peficitinib, fedratinib, and
    upadacitinib) can limit cytokine storm and hyper-inflammation by suppressing these
    signaling cascades. IL interleukin, IFN interferones, IFNAR type I IFNs receptor,
    ISGF IFN-stimulated gene factor, R receptor, sIL-6R soluble interleukin receptor,
    JAK Janus kinase, STAT signal transducer and activator of transcription, NF-κB
    nuclear factor κB. Figure created using BioRender software
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - il6
  - il6st
  - stat1b
  - stat4
  - tyk2
  - irf9
  - IL6
  - IL1A
  - IL6ST
  - NM
  - LRPPRC
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - NFKB1
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - IFNAR1
  - IFNAR2
  - IRF9
  - IFNA1
  - IFNB1
---
